Email alerts
Advanced Search
  • Mar 1, 2012
    Medtronic Seeking Long-Distance Runners Who Benefit from Medical Technology
    “Global Heroes” Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October

    MINNEAPOLIS--(BUSINESS WIRE)--Mar. 1, 2012-- Medtronic, Inc. (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the...

  • Feb 29, 2012
    Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
    World’s First Insulin Pump with Low Glucose Suspend Showed Reduces Time Spent in Low Threshold Range

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 29, 2012-- In the next step toward the development of an artificial pancreas, Medtronic, Inc. (NYSE:MDT) today announced that the results of the in-clinic ASPIRE...

  • Feb 23, 2012
    Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 23, 2012-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Citi Healthcare Conference...

  • Feb 21, 2012
    Medtronic Reports Third Quarter Earnings
    Revenue of $3.9 Billion Driven by International Revenue Growth of 6% on a Constant Currency Basis, 7% as Reported

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 21, 2012-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2012, which ended January 27, 2012. The company...

  • Feb 17, 2012
    Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
    Distinguished by Superior Deliverability and Diabetes Indication, New Heart Device Becomes Available to Cath Labs Nationwide

    MINNEAPOLIS--(BUSINESS WIRE)--Feb. 17, 2012-- Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (

Show 5102550100 per page